| Year |
Citation |
Score |
| 2024 |
Stover KR, Stafford PM, Damian AC, Pasangulapati JP, Goodwin-Tindall J, López Vásquez LM, Lee S, Yang SP, Reed MA, Barden CJ, Weaver DF. Development and Optimization of a Target Engagement Model of Brain IDO Inhibition for Alzheimer's Disease. Current Alzheimer Research. PMID 38288825 DOI: 10.2174/0115672050283199240111111801 |
0.784 |
|
| 2023 |
Savonije K, Meek A, Weaver DF. Indoleamine 2,3-Dioxygenase as a Therapeutic Target for Alzheimer's Disease and Geriatric Depression. Brain Sciences. 13. PMID 37371332 DOI: 10.3390/brainsci13060852 |
0.781 |
|
| 2022 |
Gupta M, Weaver DF. Alzheimer's: The ABCDE Paradigm. Acs Chemical Neuroscience. 13: 1355-1357. PMID 35427106 DOI: 10.1021/acschemneuro.2c00195 |
0.735 |
|
| 2022 |
Meier-Stephenson FS, Meier-Stephenson VC, Carter MD, Meek AR, Wang Y, Pan L, Chen Q, Jacobo S, Wu F, Lu E, Simms GA, Fisher L, McGrath AJ, Fermo V, Barden CJ, ... ... Weaver DF, et al. Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolites. Alzheimer's & Dementia (New York, N. Y.). 8: e12283. PMID 35415204 DOI: 10.1002/trc2.12283 |
0.681 |
|
| 2021 |
Gupta M, Weaver DF. Microsecond molecular dynamics studies of cholesterol-mediated myelin sheath degeneration in early Alzheimer's disease. Physical Chemistry Chemical Physics : Pccp. 24: 222-239. PMID 34878462 DOI: 10.1039/d1cp03844c |
0.718 |
|
| 2021 |
Gupta M, Weaver DF. Axonal plasma membrane-mediated toxicity of cholesterol in Alzheimer's disease: A microsecond molecular dynamics study. Biophysical Chemistry. 281: 106718. PMID 34808480 DOI: 10.1016/j.bpc.2021.106718 |
0.717 |
|
| 2021 |
Gupta M, Weaver DF. COVID-19 as a Trigger of Brain Autoimmunity. Acs Chemical Neuroscience. PMID 34213312 DOI: 10.1021/acschemneuro.1c00403 |
0.72 |
|
| 2021 |
Meek A, Weaver DF. Drug-Receptor Interactions: It is a Numbers Game. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-2. PMID 34183078 DOI: 10.1017/cjn.2021.152 |
0.757 |
|
| 2021 |
Kolaj I, Wang Y, Ye K, Meek A, Liyanage SI, Santos C, Weaver DF. Ferulic acid amide derivatives with varying inhibition of amyloid-β oligomerization and fibrillization. Bioorganic & Medicinal Chemistry. 43: 116247. PMID 34157569 DOI: 10.1016/j.bmc.2021.116247 |
0.796 |
|
| 2021 |
Weaver DF, Zheng Y, Stafford PM, Stover KR, Mohan DC, Gupta M, Keske EC, Schiavini P, Villar L, Wu F, Kreft A, Thomas K, Raaphorst E, Pasangulapati JP, Alla SR, et al. Discovery of a series of 2-((1-phenyl-1H-imidazol-5-yl)methyl)-1H-indoles as indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. Chemmedchem. PMID 33759400 DOI: 10.1002/cmdc.202100107 |
0.733 |
|
| 2021 |
Mancini RS, Barden CJ, Weaver DF, Reed MA. Furazans in Medicinal Chemistry. Journal of Medicinal Chemistry. PMID 33569941 DOI: 10.1021/acs.jmedchem.0c01901 |
0.757 |
|
| 2020 |
Wang Z, Wang Y, Vilekar P, Yang SP, Gupta M, Oh MI, Meek A, Doyle L, Villar L, Brennecke A, Liyanage I, Reed M, Barden C, Weaver DF. Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide. Peerj. 8: e9533. PMID 32704455 DOI: 10.7717/Peerj.9533 |
0.747 |
|
| 2020 |
Brennecke A, Villar L, Wang Z, Doyle LM, Meek A, Reed M, Barden C, Weaver DF. Is Inhaled Furosemide a Potential Therapeutic for COVID-19? The American Journal of the Medical Sciences. PMID 32622469 DOI: 10.1016/J.Amjms.2020.05.044 |
0.769 |
|
| 2020 |
Oh MI, Oh CI, Weaver DF. Effect of Cholesterol on the Structure of Networked Water at the Surface of a Model Lipid Membrane. The Journal of Physical Chemistry. B. PMID 32271578 DOI: 10.1021/Acs.Jpcb.0C01889 |
0.762 |
|
| 2019 |
Liyanage SI, Weaver DF. Misfolded proteins as a therapeutic target in Alzheimer's disease. Advances in Protein Chemistry and Structural Biology. 118: 371-411. PMID 31928732 DOI: 10.1016/Bs.Apcsb.2019.08.003 |
0.343 |
|
| 2019 |
Gupta M, Bogdanowicz T, Reed MA, Barden CJ, Weaver DF. THE BRAIN EXPOSURE EFFICIENCY (BEE) SCORE. Acs Chemical Neuroscience. PMID 31815431 DOI: 10.1021/acschemneuro.9b00650 |
0.778 |
|
| 2019 |
Oh MI, Gupta M, Oh CI, Weaver DF. Understanding the effect of nanoconfinement on the structure of water hydrogen bond networks. Physical Chemistry Chemical Physics : Pccp. PMID 31769468 DOI: 10.1039/c9cp05014k |
0.756 |
|
| 2019 |
Fertan E, Stover KRJ, Brant MG, Stafford PM, Kelly B, Diez-Cecilia E, Wong AA, Weaver DF, Brown RE. Effects of the Novel IDO Inhibitor DWG-1036 on the Behavior of Male and Female 3xTg-AD Mice. Frontiers in Pharmacology. 10: 1044. PMID 31607909 DOI: 10.3389/fphar.2019.01044 |
0.453 |
|
| 2019 |
Gupta M, Lee HJ, Barden CJ, Weaver DF. THE BLOOD-BRAIN BARRIER (BBB) SCORE. Journal of Medicinal Chemistry. PMID 31603678 DOI: 10.1021/acs.jmedchem.9b01220 |
0.781 |
|
| 2019 |
Liyanage SI, Gupta M, Wu F, Taylor M, Carter MD, Weaver DF. Inhibition of Pantothenate Synthetase by Analogs of β-Alanine Precursor Ineffective as an Antibacterial Strategy. Chemotherapy. 1-6. PMID 31167192 DOI: 10.1159/000499899 |
0.763 |
|
| 2019 |
Oh MI, Gupta M, Weaver DF. Understanding Water Structure in an Ion-Pair Solvation Shell in the Vicinity of a Water/Membrane Interface. The Journal of Physical Chemistry. B. PMID 31009219 DOI: 10.1021/acs.jpcb.9b01331 |
0.759 |
|
| 2018 |
Mancini RS, Wang Y, Weaver DF. Phenylindanes in Brewed Coffee Inhibit Amyloid-Beta and Tau Aggregation. Frontiers in Neuroscience. 12: 735. PMID 30369868 DOI: 10.3389/Fnins.2018.00735 |
0.316 |
|
| 2018 |
Kolaj I, Imindu Liyanage S, Weaver DF. Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform. Neurochemistry International. 120: 99-111. PMID 30098379 DOI: 10.1016/J.Neuint.2018.08.001 |
0.362 |
|
| 2018 |
Brant MG, Goodwin-Tindall J, Stover KR, Stafford PM, Wu F, Meek AR, Schiavini P, Wohnig S, Weaver DF. Identification of Potent Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors Based on a Phenylimidazole Scaffold. Acs Medicinal Chemistry Letters. 9: 131-136. PMID 29456801 DOI: 10.1021/Acsmedchemlett.7B00488 |
0.746 |
|
| 2017 |
Weaver DF, Meek A, Barden C, Reed M, Taylor M, Wang Y, Brant M, Stafford P, Kelly B, Diez EC. [P4-031]: ALZHEIMER'S DISEASE AS A DISORDER OF TRYPTOPHAN METABOLISM Alzheimer's & Dementia. 13: P1267-P1267. DOI: 10.1016/J.Jalz.2017.06.1895 |
0.304 |
|
| 2016 |
Russell S, Rahmani R, Jones AJ, Newson H, Neilde K, Cotillo I, Rahmani Khajouei M, Ferrins L, Qureishi S, Nguyen N, Martínez-Martínez MS, Weaver DF, Kaiser M, Riley J, Thomas J, et al. Hit-to-Lead Optimisation of a Novel Class of Potent, Broad-Spectrum Trypanosomacides. Journal of Medicinal Chemistry. PMID 27548560 DOI: 10.1021/Acs.Jmedchem.6B00442 |
0.312 |
|
| 2016 |
Weaver DF. Alzheimer's disease Neurology. 87: e33-e33. DOI: 10.1212/Wnl.0000000000002885 |
0.329 |
|
| 2016 |
Reed M, Banfield S, Barden C, Bhattacharya A, Lu E, Sweeting B, Taylor M, Wang Y, Weaver DF, Wu F, Yadav A, Yang S. Discovery Of Small Molecule Dual Inhibitors Of Both Abeta And Tau Oligomerization Alzheimers & Dementia. 12: 432. DOI: 10.1016/J.Jalz.2016.06.826 |
0.309 |
|
| 2015 |
MacLean MA, Diez-Cecilia E, Lavery CB, Reed MA, Wang Y, Weaver DF, Stradiotto M. Diversification of edaravone via palladium-catalyzed hydrazine cross-coupling: Applications against protein misfolding and oligomerization of beta-amyloid. Bioorganic & Medicinal Chemistry Letters. PMID 26598460 DOI: 10.1016/J.Bmcl.2015.11.022 |
0.365 |
|
| 2015 |
Barden C, Meier-Stephenson F, Carter M, Banfield S, Diez E, Kelly B, Lu E, Meek A, Meier-Stephenson V, Pan L, Simms G, Sweeting B, Wang Y, Wu F, Yadav A, ... ... Weaver D, et al. Design and development of drugs for Alzheimer’s dementia as a protein misfolding disorder Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques. 42: S16-S16. DOI: 10.1017/Cjn.2015.95 |
0.372 |
|
| 2014 |
Taylor M, Reed M, Weaver D, Barden C, Banfield S, Yadav A, Lu E, Yang S, Sweeting B, Gallant P, Wang Y. P4-208: CHARACTERIZATION AND OPTIMIZATION OF NEW CHEMICAL ENTITY ANTI-PROTEIN MISFOLDING AGENTS Alzheimer's & Dementia. 10: P864-P864. DOI: 10.1016/J.Jalz.2014.05.1726 |
0.361 |
|
| 2013 |
Meek AR, Simms GA, Weaver DF. Searching for an endogenous anti-Alzheimer molecule: identifying small molecules in the brain that slow Alzheimer disease progression by inhibition of ß-amyloid aggregation. Journal of Psychiatry & Neuroscience : Jpn. 38: 269-75. PMID 23394811 DOI: 10.1503/Jpn.120166 |
0.789 |
|
| 2013 |
Weaver IN, Weaver DF. A simple electrotopological index for quantitative structure-activity relationship correlation of physical properties with biomolecular activities Journal of Mathematical Chemistry. 51: 811-816. DOI: 10.1007/S10910-013-0143-X |
0.4 |
|
| 2012 |
Meek AR, Simms GA, Weaver DF. In silico search for an endogenous anti-Alzheimer's molecule - Screening amino acid metabolic pathways Canadian Journal of Chemistry. 90: 865-873. DOI: 10.1139/V2012-074 |
0.37 |
|
| 2010 |
Carter MD, Simms GA, Weaver DF. The development of new therapeutics for Alzheimer's disease. Clinical Pharmacology and Therapeutics. 88: 475-86. PMID 20811351 DOI: 10.1038/Clpt.2010.165 |
0.356 |
|
| 2010 |
Matta CF, Arabi AA, Weaver DF. The bioisosteric similarity of the tetrazole and carboxylate anions: clues from the topologies of the electrostatic potential and of the electron density. European Journal of Medicinal Chemistry. 45: 1868-72. PMID 20133027 DOI: 10.1016/J.Ejmech.2010.01.025 |
0.377 |
|
| 2010 |
Barden CJ, Weaver DF. The rise of micropharma. Drug Discovery Today. 15: 84-7. PMID 19837185 DOI: 10.1016/J.Drudis.2009.10.001 |
0.767 |
|
| 2009 |
Weaver DF, Barden C. Don't overlook the rigorously reviewed novel work in patents. Nature. 461: 340. PMID 19759596 DOI: 10.1038/461340B |
0.74 |
|
| 2008 |
Weaver DF, Carter MD. Does NSAID use modify cognitive trajectories in the elderly? The cache county study. Neurology. 70: 895. PMID 18332350 DOI: 10.1212/01.Wnl.0000307673.96325.Ab |
0.582 |
|
| 2007 |
Campagna-Slater V, Weaver DF. Anaesthetic binding sites for etomidate and propofol on a GABAA receptor model. Neuroscience Letters. 418: 28-33. PMID 17412502 DOI: 10.1016/J.Neulet.2007.02.091 |
0.757 |
|
| 2007 |
Campagna-Slater V, Weaver DF. Molecular modelling of the GABAA ion channel protein. Journal of Molecular Graphics & Modelling. 25: 721-30. PMID 16877018 DOI: 10.1016/J.Jmgm.2006.06.001 |
0.754 |
|
| 2006 |
Leung FH, Thompson K, Weaver DF. Evaluating spousal abuse as a potential risk factor for Alzheimer's disease: rationale, needs and challenges. Neuroepidemiology. 27: 13-6. PMID 16770080 DOI: 10.1159/000093894 |
0.311 |
|
| 2005 |
O'Brien LA, Sutherland JJ, Weaver DF, Lillicrap D. Theoretical structural explanation for Group I and Group II, type 2A von Willebrand disease mutations. Journal of Thrombosis and Haemostasis : Jth. 3: 796-7. PMID 15842374 DOI: 10.1111/J.1538-7836.2005.01219.X |
0.668 |
|
| 2005 |
Lyon AP, Wainman D, Marone S, Weaver DF. A spontaneous recurrent seizure bioassay for anti-epileptogenic molecules. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 32: 97-102. PMID 15825554 DOI: 10.1017/S0317167100016954 |
0.763 |
|
| 2005 |
Stephenson VC, Heyding RA, Weaver DF. The "promiscuous drug concept" with applications to Alzheimer's disease. Febs Letters. 579: 1338-42. PMID 15733838 DOI: 10.1016/J.Febslet.2005.01.019 |
0.36 |
|
| 2005 |
Jin AY, Kohn H, Béguin C, Andurkar SV, Stables JP, Weaver DF. A quantitative structure-activity relationship study for α-substituted acetamido-N-benzylacetamide derivatives - A novel anticonvulsant drug class Canadian Journal of Chemistry. 83: 37-45. DOI: 10.1139/V04-160 |
0.396 |
|
| 2004 |
Wu F, Buhendwa MG, Weaver DF. Benzhydryl as an efficient selective nitrogen protecting group for uracils. The Journal of Organic Chemistry. 69: 9307-9. PMID 15609973 DOI: 10.1021/Jo0485076 |
0.353 |
|
| 2004 |
Sutherland JJ, Weaver DF. Three-dimensional quantitative structure-activity and structure-selectivity relationships of dihydrofolate reductase inhibitors. Journal of Computer-Aided Molecular Design. 18: 309-31. PMID 15595459 DOI: 10.1023/B:Jcam.0000047814.85293.Da |
0.665 |
|
| 2004 |
Sutherland JJ, O'Brien LA, Weaver DF. A comparison of methods for modeling quantitative structure-activity relationships. Journal of Medicinal Chemistry. 47: 5541-54. PMID 15481990 DOI: 10.1021/Jm0497141 |
0.678 |
|
| 2004 |
Sutherland JJ, O'Brien LA, Lillicrap D, Weaver DF. Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations. Journal of Molecular Modeling. 10: 259-70. PMID 15322948 DOI: 10.1007/S00894-004-0194-9 |
0.676 |
|
| 2004 |
Sutherland JJ, O'Brien LA, Weaver DF. Pruned receptor surface models and pharmacophores for three-dimensional database searching. Journal of Medicinal Chemistry. 47: 3777-87. PMID 15239656 DOI: 10.1021/Jm049896Z |
0.692 |
|
| 2004 |
Lyon A, Marone S, Wainman D, Weaver DF. Implementing a bioassay to screen molecules for antiepileptogenic activity: chronic pilocarpine versus subdudral haematoma models. Seizure. 13: 82-6. PMID 15129835 DOI: 10.1016/S1059-1311(03)00153-5 |
0.78 |
|
| 2004 |
Duan G, Smith VH, Weaver DF. Validation of the Applicability of Force Fields to Reproduce Ab Initio Noncovalent Interactions Involving Aromatic Groups Advances in Quantum Chemistry. 47: 65-92. DOI: 10.1016/S0065-3276(04)47005-1 |
0.758 |
|
| 2003 |
Sutherland JJ, O'Brien LA, Weaver DF. Spline-fitting with a genetic algorithm: a method for developing classification structure-activity relationships. Journal of Chemical Information and Computer Sciences. 43: 1906-15. PMID 14632439 DOI: 10.1021/Ci034143R |
0.686 |
|
| 2003 |
Béguin C, Andurkar SV, Jin AY, Stables JP, Weaver DF, Kohn H. Functionalized amido ketones: new anticonvulsant agents. Bioorganic & Medicinal Chemistry. 11: 4275-85. PMID 12951158 DOI: 10.1016/S0968-0896(03)00434-6 |
0.617 |
|
| 2003 |
Sutherland JJ, Weaver DF. Development of quantitative structure-activity relationships and classification models for anticonvulsant activity of hydantoin analogues. Journal of Chemical Information and Computer Sciences. 43: 1028-36. PMID 12767162 DOI: 10.1021/Ci025639W |
0.68 |
|
| 2003 |
Tan CY, Wainman D, Weaver DF. N-, alpha-, and beta-Substituted 3-Aminopropionic acids: design, syntheses and antiseizure activities. Bioorganic & Medicinal Chemistry. 11: 113-21. PMID 12467714 DOI: 10.1016/S0968-0896(02)00330-9 |
0.568 |
|
| 2003 |
Jones RS, Sutherland J, Weaver DF. Synthesis of 4-ethoxycarbonyl-5-arylisoxazolidines via regioselective cycloaddition Synthetic Communications. 33: 43-51. DOI: 10.1081/Scc-120015557 |
0.662 |
|
| 2003 |
Carter MD, Weaver DF. Ab initio molecular modeling of imadazolium interaction with 5-hydroxy- and 5-methoxyindole: Implications for melatonin-based inhibition of Alzheimer β-amyloid fibril formation Journal of Molecular Structure: Theochem. 626: 279-285. DOI: 10.1016/S0166-1280(03)00100-3 |
0.443 |
|
| 2002 |
Duan G, Smith VH, Weaver DF. Data mining, ab initio, and molecular mechanics study on conformation of phenylalanine and its interaction with neighboring backbone amide groups in proteins International Journal of Quantum Chemistry. 90: 669-683. DOI: 10.1002/Qua.956 |
0.766 |
|
| 2001 |
Duan G, Smith VH, Weaver DF. Characterization of aromatic-thiol π-type hydrogen bonding and phenylalanine-cysteine side chain interactions through ab initio calculations and protein database analyses Molecular Physics. 99: 1689-1699. DOI: 10.1080/00268970110063917 |
0.76 |
|
| 2000 |
Hồ M, Clark BJ, Smith VH, Weaver DF, Gatti C, Sagar RP, Esquivel RO. Shannon information entropies of molecules and functional groups in the self-consistent reaction field The Journal of Chemical Physics. 112: 7572-7580. DOI: 10.1063/1.481366 |
0.736 |
|
| 2000 |
Duan G, Smith, VH, Weaver DF. Characterization of Aromatic−Amide(Side-Chain) Interactions in Proteins through Systematic ab Initio Calculations and Data Mining Analyses The Journal of Physical Chemistry A. 104: 4521-4532. DOI: 10.1021/Jp993381F |
0.693 |
|
| 2000 |
Kim ST, Weaver DF. Theoretical studies on Alzheimer's disease: Structures of β-amyloid aggregates Journal of Molecular Structure: Theochem. 527: 127-138. DOI: 10.1016/S0166-1280(00)00485-1 |
0.332 |
|
| 2000 |
Duan G, Smith VH, Weaver DF. A data mining and ab initio study of the interaction between the aromatic and backbone amide groups in proteins International Journal of Quantum Chemistry. 80: 44-60. DOI: 10.1002/1097-461X(2000)80:1<44::Aid-Qua4>3.0.Co;2-K |
0.756 |
|
| 2000 |
H� M, Schmider HL, Weaver DF, Smith VH, Sagar RP, Esquivel RO. Shannon entropy of chemical changes:SN2 displacement reactions International Journal of Quantum Chemistry. 77: 376-382. DOI: 10.1002/(Sici)1097-461X(2000)77:1<376::Aid-Qua37>3.0.Co;2-3 |
0.728 |
|
| 1999 |
Duan G, Smith VH, Weaver DF. An ab initio and data mining study on aromatic–amide interactions Chemical Physics Letters. 310: 323-332. DOI: 10.1016/S0009-2614(99)00804-0 |
0.764 |
|
| 1998 |
Hồ M, Weaver DF, Smith VH, Sagar RP, Esquivel RO. Calculating the logarithmic mean excitation energy from the Shannon information entropy of the electronic charge density Physical Review A. 57: 4512-4517. DOI: 10.1103/Physreva.57.4512 |
0.721 |
|
| 1998 |
Hò M, Weaver DF, Smith VH, Sagar RP, Esquivel RO, Yamamoto S. An information-entropic study of correlated densities of the water molecule Journal of Chemical Physics. 109: 10620-10627. DOI: 10.1063/1.477761 |
0.733 |
|
| 1998 |
Hồ M, Smith VH, Weaver DF, Gatti C, Sagar RP, Esquivel RO. Molecular similarity based on information entropies and distances The Journal of Chemical Physics. 108: 5469-5475. DOI: 10.1063/1.476316 |
0.734 |
|
| 1997 |
Tan CY, Weaver DF. Molecular pathogenesis of alcohol withdrawal seizures: the modified lipid-protein interaction mechanism. Seizure. 6: 255-74. PMID 9304717 DOI: 10.1016/S1059-1311(97)80073-8 |
0.54 |
|
| 1996 |
Rozas I, Weaver DF. Ab initio study of the methylsulfonate and phenylsulfonate anions Journal of the Chemical Society. Perkin Transactions 2. 3: 461-465. DOI: 10.1039/P29960000461 |
0.377 |
|
| 1995 |
Nagy J, Weaver DF, Smith VH. Ab initio methane dimer intermolecular potentials Molecular Physics. 85: 1179-1192. DOI: 10.1080/00268979500101751 |
0.578 |
|
| 1995 |
Nagy J, Smith VH, Weaver DF. Critical Evaluation of Benzene Analytical Nonbonded Force Fields. Reparametrization of the MM3 Potential The Journal of Physical Chemistry. 99: 13868-13875. DOI: 10.1021/J100038A018 |
0.587 |
|
| 1995 |
Nagy J, Weaver DF, Smith VH. A Comprehensive Study of Alkane Nonbonded Empirical Force Fields. Suggestions for Improved Parameter Sets The Journal of Physical Chemistry. 99: 8058-8065. DOI: 10.1021/J100020A032 |
0.588 |
|
| 1995 |
Graham JE, Ripley DC, Smith JT, Smith VH, Weaver DF. Theoretical studies applied to drug design: ab initio electronic distributions in bioisosteres Journal of Molecular Structure: Theochem. 343: 105-109. DOI: 10.1016/0166-1280(95)90533-2 |
0.628 |
|
| 1995 |
Nagy J, Smith VH, Weaver DF. Validation of a reparameterized MM3 non-bonded force field for hydrocarbons: crystal lattice studies of C60 and C70 and adsorption of hydrocarbons onto graphite Journal of Molecular Structure: Theochem. 358: 71-77. DOI: 10.1016/0166-1280(95)04339-X |
0.62 |
|
| 1995 |
H� M, Sagar RP, Weaver DF, Smith VH. An investigation of the dependence of Shannon information entropies and distance measures on molecular geometry International Journal of Quantum Chemistry. 56: 109-115. DOI: 10.1002/Qua.560560811 |
0.727 |
|
| 1995 |
Hô M, Sagar RP, Schmider H, Weaver DF, Smith VH. Measures of distance for atomic charge and momentum densities and their relationship to physical properties International Journal of Quantum Chemistry. 53: 627-633. DOI: 10.1002/Qua.560530606 |
0.72 |
|
| 1994 |
Bikker JA, Kubanek J, Weaver DF. Quantum pharmacologic studies applicable to the design of anticonvulsants: theoretical conformational analysis and structure-activity studies of barbiturates. Epilepsia. 35: 411-25. PMID 8156967 DOI: 10.1111/J.1528-1157.1994.Tb02454.X |
0.405 |
|
| 1994 |
Edgecombe KE, Weaver DF, Smith Jr. VH. Electronic structure analysis of compounds of interest in drug design: mono- and dicarboxylated pyridines Canadian Journal of Chemistry. 72: 1388-1403. DOI: 10.1139/V94-174 |
0.428 |
|
| 1994 |
Nagy J, Smith VH, Weaver DF. Calculation of second virial coefficients of alkanes with the MM2 and MM3 force fields Molecular Physics. 81: 1039-1047. DOI: 10.1080/00268979400100691 |
0.6 |
|
| 1994 |
Michalak A, Mrozek J, Smith VH, Weaver DF. A molecular orbital study of two vasoconstricting mycotoxins: butenolide and ergotamine Journal of Molecular Structure: Theochem. 305: 1-7. DOI: 10.1016/0166-1280(94)80135-5 |
0.628 |
|
| 1991 |
Weaver DF, Khalil M, Smith VH. An AMI semi-empirical quantum mechanical study of the polyhydration of amino acid side chains Journal of Molecular Structure: Theochem. 226: 73-86. DOI: 10.1016/0166-1280(91)80006-T |
0.609 |
|
| 1991 |
Khalil M, Woods RJ, Weaver DF, Smith VH. An examination ofintermolecular andintramolecular hydrogen bonding in biomolecules by AM1 and MNDO/M semiempirical molecular orbital studies Journal of Computational Chemistry. 12: 584-593. DOI: 10.1002/Jcc.540120508 |
0.614 |
|
| 1988 |
Wolfe S, Bowers RJ, Shin H, Sohn C, Weaver DF, Yang K. Phenceptin: a biomimetic model of the phenytoin receptor Canadian Journal of Chemistry. 66: 2751-2762. DOI: 10.1139/V88-425 |
0.535 |
|
| 1988 |
Wolfe S, Khalil M, Weaver DF. MMPEN: Development and evaluation of penicillin parameters for Allinger's MMP2(85)programme Canadian Journal of Chemistry. 66: 2715-2732. DOI: 10.1139/V88-423 |
0.523 |
|
| 1988 |
Wolfe S, Bruder S, Weaver DF, Yang K. Theoretical conformational analysis of peptides. Evolution of a strategy and its application to cholecystokinin analogs Canadian Journal of Chemistry. 66: 2703-2714. DOI: 10.1139/V88-422 |
0.516 |
|
| 1988 |
Wolfe S, Weaver DF, Yang K. MMPEP: Development and evaluation of peptide parameters for Allinger's MMP2(85) programme, including calculations on crambin and insulin Canadian Journal of Chemistry. 66: 2687-2702. DOI: 10.1139/V88-421 |
0.521 |
|
| 1988 |
Wolfe S, Bowers RJ, Shin HS, Sohn CK, Weaver DF, Yang K. Phenceptin: A biomimetic model of the phenytoin receptor Canadian Journal of Chemistry. 66: 2751-2762. |
0.422 |
|
| 1988 |
Wolfe S, Bruder S, Weaver DF, Yang K. Theoretical conformational analysis of peptides. Evolution of a strategy and its application to cholecystokinin analogs Canadian Journal of Chemistry. 66: 2703-2713. |
0.435 |
|
| 1988 |
Wolfe S, Khalil M, Weaver DF. MMPEN: Development and evaluation of penicillin parameters for Allinger's MMP2(85) programme Canadian Journal of Chemistry. 66: 2715-2732. |
0.432 |
|
| 1988 |
Wolfe S, Weaver DF, Yang K. MMPEP: Development and evaluation of peptide parameters for Allinger's MMP2(85) programme, including calculations on crambin and insulin Canadian Journal of Chemistry. 66: 2687-2702. |
0.44 |
|
| 1984 |
Wolfe S, LaJohn LA, Weaver DF. On the structures of alpha-lithiated sulfoxide, sulfone and sulfonium systems. Implications for the stereochemistry of functionalization of carbon atoms adjacent to sulfur Tetrahedron Letters. 25: 2863-2866. DOI: 10.1016/S0040-4039(01)81310-1 |
0.511 |
|
| Show low-probability matches. |